Sherbrooke Park Advisers LLC Invests $584,000 in Genpact Limited (NYSE:G)

Sherbrooke Park Advisers LLC purchased a new stake in shares of Genpact Limited (NYSE:G - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 13,598 shares of the business services provider's stock, valued at approximately $584,000.

Other hedge funds have also recently made changes to their positions in the company. ProShare Advisors LLC increased its holdings in shares of Genpact by 6.2% during the fourth quarter. ProShare Advisors LLC now owns 7,591 shares of the business services provider's stock valued at $326,000 after acquiring an additional 445 shares in the last quarter. Quantinno Capital Management LP increased its holdings in shares of Genpact by 60.8% during the fourth quarter. Quantinno Capital Management LP now owns 276,273 shares of the business services provider's stock valued at $11,866,000 after acquiring an additional 104,448 shares in the last quarter. Man Group plc grew its holdings in Genpact by 51.6% during the fourth quarter. Man Group plc now owns 81,306 shares of the business services provider's stock worth $3,492,000 after buying an additional 27,684 shares in the last quarter. Nomura Holdings Inc. bought a new stake in Genpact during the fourth quarter worth $925,000. Finally, Mubadala Investment Co PJSC bought a new stake in Genpact during the fourth quarter worth $2,421,000. 96.03% of the stock is owned by institutional investors and hedge funds.

Genpact Price Performance

Shares of Genpact stock traded up $0.33 during trading on Tuesday, hitting $44.43. The stock had a trading volume of 1,145,587 shares, compared to its average volume of 1,368,395. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 12 month low of $30.38 and a 12 month high of $56.76. The firm has a market cap of $7.77 billion, a price-to-earnings ratio of 15.64, a P/E/G ratio of 1.84 and a beta of 1.02. The business's 50-day moving average is $47.82 and its 200 day moving average is $47.28.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. The firm had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The company's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter last year, the company posted $0.73 EPS. As a group, sell-side analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current year.

Insider Activity at Genpact

In related news, Director Nicholas C. Gangestad purchased 2,000 shares of Genpact stock in a transaction that occurred on Tuesday, May 13th. The shares were acquired at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the transaction, the director now directly owns 2,000 shares in the company, valued at $87,940. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.07% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on G. Mizuho upped their price target on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Robert W. Baird dropped their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Needham & Company LLC decreased their price objective on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, May 8th. Finally, TD Cowen raised Genpact from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $50.71.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.